Cidara Therapeutics to Present New Clinical and Preclinical Data for Rezafungin and Influenza AVCs at IDWeek 2020

NEXT STORY
Ayala Pharmaceuticals to Host Virtual KOL Event Reviewing Interim Data Presented at ESMO 2020 from Ongoing Phase 2 ACCURACY Trial of AL101 for the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma
PREV STORY
Home Infusion Therapy Market to Exhibit 2.2% CAGR and Reach USD 86.89 Billion by 2027; Rising Prevalence of COVID19 Pandemic to Promote Growth, says Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Saniona AB: Saniona publishes its interim report for the second quarter 2017

PRESS RELEASE 23 August 2017 Financial highlights H1 2017 (H1 2016) ·         Net revenues were ...

author_avatar
NASDAQ Market News

Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen injection) in Canada

First and only treatment of its kind for Canadians with Hereditary Transthyretin-mediated Amyloidosis (hATTR ...

author_avatar
NASDAQ Market News

IASLC Mengundang Para Profesional Kanker Paru-Paru untuk Mengikuti Survei Global Pengujian Molekuler

Pemimpin Global dalam Survei Keganasan Torakal untuk Menilai Peningkatan Pengujian Molekuler di Seluruh DuniaDENVER, ...

author_avatar
NASDAQ Market News